Dr. Joel Silver How do myeloma and chronic lymphocytic leukemia (CLL) develop? What are some risk factors associated with those malignancies? A. We don’t know what causes CLL. We do know that people in some occupations or with a certain exposure history might be at higher risk, and that CLL generally affects older people. … Continued
As the third most common cancer in the United States, colorectal cancer (CRC) affects about 1 in 20 Americans. However, incidence and death rates for cancer of the colorectum have significantly decreased over the past several decades as a result of increased screening and drastic improvements in treatment. In Maryland alone, approximately 70% of adults … Continued
Ralph V. Boccia, MD, a cancer specialist at RCCA Maryland, provides some insight into recent colorectal cancer trends and treatments that are giving new hope to doctors, researchers and patients nationwide. Overall, Dr. Boccia finds much to be encouraged by, but also points to the need for awareness of a concerning development in the field … Continued
HACKENSACK, N.J., Nov. 22, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates (RCCA) is expanding its cancer care payment initiative with UnitedHealthcare to RCCA patients in Maryland who are covered by UnitedHealthcare benefit plans. The program, made available at RCCA New Jersey locations in January, rewards physicians for focusing on best treatment practices, quality patient care and … Continued
Regional Cancer Care Associates (RCCA) and Aetna (NYSE: AET) announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients.
Seth Howard Berk, MD, a hematologist and medical oncologist with RCCA, reveals four facts that he shares with his patients when they ask about clinical trials. First, a drug has been thoroughly tested well before it reaches the clinical trial stage. Pre-clinical trial testing involves looking at a drug’s effects on animals as well as … Continued
A recent article on nj.com, titled “Prostate cancer: Answers to three key questions about trends in New Jersey, recent advances,” reveals the truth about three common prostate cancer myths. According to experts at the American Cancer Society, National Cancer Institute, and Food and Drug Administration, the majority of men diagnosed with prostate cancer do not … Continued
A recent article on nj.com, titled “Bladder cancer trends in Montgomery and Prince George’s counties: Welcome news – and 3 facts you need to know” highlights the expertise of RCCA’s own Dr. Ralph V. Boccia. According to the board-certified hematologist and medical oncologist, there are three main facts to keep in mind about bladder cancer. … Continued
Dr. Seth Howard Berk, a board-certified hematologist and medical oncologist who practices in Mount Holly, NJ with Regional Cancer Care Associates (RCCA), discusses new developments in oncology treatments for skin disorders. Dr. Berk mentions that many of the new tools used in combating skin cancers focus on harnessing the power of the immune system, and … Continued
Addressing the value changes that CMS is mandating takes enormous planning and study. Many oncology practices are grappling with the new programs that the government payer has asked them to adopt.